Evidence map›Paper›PMID 19636353›Full record

ArticlePLoS medicine2009

Can prenatal malaria exposure produce an immune tolerant phenotype? A prospective birth cohort study in Kenya.

Indu Malhotra, Arlene Dent, Peter Mungai, Alex Wamachi, John H Ouma, David L Narum, Eric Muchiri, Daniel J Tisch, Christopher L King

Open access · goldAbstract read
In one paragraph

Article in PLoS medicine, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 97 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
97citing papers in PubMed, 3 pooled it
13.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

97 citing papers in PubMed, 3 syntheses or guidelines pooled it, 162 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Review
  14. Article
  15. Article
  16. Article
  17. Sex-Linked Differences in Malaria Risk Across the Lifespan.Current topics in microbiology and immunology · 2023
    Review
  18. Review
  19. Article
  20. Review

37 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Indu MalhotraCenter for Global Health and Diseases, Case Western Reserve University, Cleveland, Ohio, USA.
Arlene Dent
Peter Mungai
Alex Wamachi
John H Ouma
David L Narum
Eric Muchiri
Daniel J Tisch
Christopher L King
Center for Global Health · USCase Western Reserve University · USKenya Medical Research Institute · KENational Institute of Allergy and Infectious Diseases · US

Funding

Mass drug treatment and vector control of filariasisU19AI065717 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI KAZURA, JAMES WALTER · 2005 to 2009
$4.2M
Fetal Immunity to Falciparum MalariaR01AI064687 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI KING, CHRISTOPHER L · 2005 to 2015
$3.7M
HIV, Malaria and Neurobehavioral Development in Early ChildhoodR01MH080601 · NIMH · CASE WESTERN RESERVE UNIVERSITY · PI HOLDING, PENNY A · 2007 to 2011
$2.9M
New Approaches to Schistosome vaccine antigen discoveryR01AI054711 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI KING, CHRISTOPHER L · 2005 to 2008
$1.4M
NIAID NIH HHS AI054711NIAID NIH HHS AI064687NIAID NIH HHS AI065717NIAID NIH HHS R01 AI054711NIAID NIH HHS R01 AI064687NIAID NIH HHS U19 AI065717NIMH NIH HHS MH080601NIMH NIH HHS R01 MH080601
6 · The paper itself

Abstract

backgroundMalaria in pregnancy can expose the fetus to malaria-infected erythrocytes or their soluble products, thereby stimulating T and B cell immune responses to malaria blood stage antigens. We hypothesized that fetal immune priming, or malaria exposure in the absence of priming (putative tolerance), affects the child's susceptibility to subsequent malaria infections. METHODS AND

findingsWe conducted a prospective birth cohort study of 586 newborns residing in a malaria-holoendemic area of Kenya who were examined biannually to age 3 years for malaria infection, and whose malaria-specific cellular and humoral immune responses were assessed. Newborns were classified as (i) sensitized (and thus exposed), as demonstrated by IFNgamma, IL-2, IL-13, and/or IL-5 production by cord blood mononuclear cells (CBMCs) to malaria blood stage antigens, indicative of in utero priming (n = 246), (ii) exposed not sensitized (mother Plasmodium falciparum [Pf]+ and no CBMC production of IFNgamma, IL-2, IL-13, and/or IL-5, n = 120), or (iii) not exposed (mother Pf-, no CBMC reactivity, n = 220). Exposed not sensitized children had evidence for prenatal immune experience demonstrated by increased IL-10 production and partial reversal of malaria antigen-specific hyporesponsiveness with IL-2+IL-15, indicative of immune tolerance. Relative risk data showed that the putatively tolerant children had a 1.61 (95% confidence interval [CI] 1.10-2.43; p = 0.024) and 1.34 (95% CI 0.95-1.87; p = 0.097) greater risk for malaria infection based on light microscopy (LM) or PCR diagnosis, respectively, compared to the not-exposed group, and a 1.41 (95%CI 0.97-2.07, p = 0.074) and 1.39 (95%CI 0.99-2.07, p = 0.053) greater risk of infection based on LM or PCR diagnosis, respectively, compared to the sensitized group. Putatively tolerant children had an average of 0.5 g/dl lower hemoglobin levels (p = 0.01) compared to the other two groups. Exposed not sensitized children also had 2- to 3-fold lower frequency of malaria antigen-driven IFNgamma and/or IL-2 production (p<0.001) and higher IL-10 release (p<0.001) at 6-month follow-ups, when compared to sensitized and not-exposed children. Malaria blood stage-specific IgG antibody levels were similar among the three groups.

conclusionsThese results show that a subset of children exposed to malaria in utero acquire a tolerant phenotype to blood-stage antigens that persists into childhood and is associated with an increased susceptibility to malaria infection and anemia. This finding could have important implications for malaria vaccination of children residing in endemic areas.

Indexed as

Immune TolerancePlasmodium falciparumAdultAnimalsAntibodies, ProtozoanAntigens, ProtozoanCells, CulturedCytokinesFemaleFetal BloodHumansInfant, NewbornKenyaMalaria, FalciparumMaleMaternal-Fetal ExchangeAntibodies, ProtozoanAntigens, Protozoanapical membrane antigen I, PlasmodiumCytokineserythrocyte-binding antigen 175, PlasmodiumMembrane ProteinsMerozoite Surface Protein 1Protozoan Proteins

Identifiers

PMID19636353
PMCPMC2707618
OpenAlexW2044099206

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.